title: [Recombinant erythropoietins--an alternative therapy to red cell blood transfusions in infants with hereditary spherocytosis].
abstract: Hereditary spherocytosis is the most frequently occurring haemolytic anaemia. Some patients manifest clinical signs during the neonatal period and require transfusion. A case of hereditary spherocytosis in neonate is presented. The use of rhEPO during the first months may be an alternative therapy to red cell transfusion.
authors.affiliation: Klinika Pediatrii Hematologii Onkologii i Endokrynologii AM w Gdańsku.
authors.forename: Magdalena
authors.initials: M
authors.lastname: Neuman-Łaniec
authors.forename: Jolanta
authors.initials: J
authors.lastname: Wierzba
authors.forename: Ninela
authors.initials: N
authors.lastname: Irga
authors.forename: Eliza
authors.initials: E
authors.lastname: Wasilewska
authors.forename: Anna
authors.initials: A
authors.lastname: Balcerska
mesh_terms: D017707:Erythrocyte Transfusion; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D006454:Hemoglobins / Q000187:drug effects / Q000378:metabolism*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D011994:Recombinant Proteins; D013103:Spherocytosis, Hereditary / Q000097:blood / Q000188:drug therapy* / Q000235:genetics; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D006454:Hemoglobins; D011994:Recombinant Proteins; D004921:Erythropoietin